MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) — Baltimore, Maryland

MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) is a clinical research site located in Baltimore, Maryland, United States 21239.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Neoplasms, Breast Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baltimore

Browse all research sites in Maryland · View every site in Baltimore

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Good Samaritan Hospital-Oncology Research ( Site 0038)?

MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) conducted?

MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) has 2 clinical trials on record, with 1 currently active. Their work covers Colorectal Neoplasms, Breast Neoplasms.

Is MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) accredited by Crixeo Clinical Trials?

MedStar Good Samaritan Hospital-Oncology Research ( Site 0038) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Good Samaritan Hospital-Oncology Research ( Site 0038)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.